ScripThe South Korean bioventure Nature Cell Co. Ltd. has received IND approval from the US FDA to start a Phase I/II clinical trial with its novel stem cell-based therapy for Alzheimer's disease (AD) Ast
In VivoIN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Corp. Advanced Cell Diagnostics Inc. Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Dia
ScripA new agreement between Sorrento Therapeutics Inc. and CHA Biotech Co. Ltd. underscores the ongoing efforts by South Korean biopharma firms to grab leading positions in the still early stage b
ScripSEOUL - Nature Cell Co. Ltd. and R Bio Co. Ltd., which are part of South Korea’s Biostar Group, have hired a contract research organization to conduct US clinical trials with the stem cell therapy Jo